Skip to content

Lung injury mechanism and target molecular drug research of chronic obstructive pulmonary disease

Lung injury mechanism and target molecular drug research of chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CCS-13003116
Enrollment
Unknown
Registered
2013-02-19
Start date
2012-03-29
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

aucte phase and admission phase:Normal treatment

Sponsors

The First Affiliated Hospital Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 85 Years

Inclusion criteria

Inclusion criteria: aged over 35, and all patients were diagnosed COPD by medical histroy, lung function and X-ray chest radiography, and the standard of diagnosis accord the ATS/ERS on the diagnosis and treatment of COPD guideline.

Exclusion criteria

Exclusion criteria: The exclusion criteria include allergies, asthma, other respiratory diseases, or a respiratory infection less than 8 weeks before entering the study.

Design outcomes

Primary

MeasureTime frame
protein;gene;inflammatory cytokin;

Countries

China

Contacts

Public ContactWenju Lu
wlu92@yahoo.com+86 13538816468

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026